ESR1 and breast cancer: Immunohistochemistry showed that 19 samples from 49 human breast cancer tissues were GPR119 positive, but there were no remarkable changes in GPR119 expression depending on TMN stages and tumor stages of patients or estrogen receptor (ER)-α (Table 1).